CYBB and Crohn disease: At the same time, NOX2 has been reported to specifically activate signaling pathways, such as Nrf2, thus becoming an important therapeutic target for chronic granulomatous and Crohn’s disease, in which severe bacterial or fungal infections and excessive inflammation are the main characteristics.